Exchange: NASDAQ·Updated 07:30 PM EST

About NRIX

About

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in Brisbane, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
317

Frequently Asked Questions

Advertisement|Remove ads.